Fortis Group Advisors’s GE HealthCare GEHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.76K Buy
90
+9
+11% +$592 ﹤0.01% 432
2026
Q1
$5.76K Hold
81
﹤0.01% 429
2025
Q4
$6.64K Hold
81
﹤0.01% 413
2025
Q3
$6.08K Hold
81
﹤0.01% 379
2025
Q2
$6K Hold
81
﹤0.01% 375
2025
Q1
$6.54K Sell
81
-26
-24% -$2.23K ﹤0.01% 332
2024
Q4
$8.36K Hold
107
﹤0.01% 322
2024
Q3
$10K Sell
107
-3,011
-97% -$253K ﹤0.01% 300
2024
Q2
$243K Sell
3,118
-1,858
-37% -$152K 0.05% 164
2024
Q1
$452K Buy
4,976
+4,762
+2,225% +$396K 0.08% 140
2023
Q4
$16.6K Buy
214
+107
+100% +$7.49K ﹤0.01% 251
2023
Q3
$7.28K Sell
107
-4,089
-97% -$298K ﹤0.01% 253
2023
Q2
$341K Buy
+4,196
New +$335K 0.09% 99

Other funds holding GEHC

Fortis Group Advisors's GEHC Position: Q2 2026 in Review

Fortis Group Advisors increased its GE HealthCare (GEHC) stake by 11% in Q2 2026, buying an estimated $592 and bringing the position to 90 shares worth $5.76K. The position accounts for ﹤0.01% of the portfolio, ranked #432.

Fortis Group Advisors first reported a position in GEHC in Q2 2023 and has held it in 13 quarters since. The position peaked at $452K in Q1 2024. 1,223 funds tracked by Wall St. Rank hold GEHC as of Q2 2026.

  • Fortis Group Advisors held 90 shares of GE HealthCare worth $5.76K as of Q2 2026.
  • Fortis Group Advisors bought 9 GE HealthCare shares in Q2 2026, an estimated $592.
  • GE HealthCare made up ﹤0.01% of Fortis Group Advisors's portfolio in Q2 2026, its #432 holding.
  • Fortis Group Advisors first reported a position in GE HealthCare in Q2 2023 and has held it in 13 quarters since.
  • Fortis Group Advisors's GE HealthCare position peaked at $452K in Q1 2024.
  • 1,223 funds tracked by Wall St. Rank held GE HealthCare as of Q2 2026.

Based on Fortis Group Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.